posted on 2018-03-28, 05:00authored byConor Tweed, Genevieve Wills, Angela Crook, Rodney Dawson, Andreas Diacon, Cheryl Louw, Timothy McHugh, Carl Mendel, Sarah Meredith, Lerato Mohapi, Michael Murphy, Stephen Murray, Sara Murthy, Andrew Nunn, Patrick Phillips, Kasha Singh, M. Spigelman, S. Gillespie
Table S1. Daily dosing of TB medications for patients randomised into REMoxTB based on weight at screening. Table S2. The RousselâUclaf causality assessment method (RUCAM) for causality assessment of adverse drug reactions. Table S3. ChildâPugh scoring system for grading the prognosis of chronic liver disease. Figure S1. Graphs showing the median ALT and AST values for all patients at scheduled blood draws in all three treatment arms. (DOCX 318 kb)